Mianserin

CAS 24219-97-4 3 current records 1 historicalSmall Molecule

Who holds supplier records for Mianserin? 3 organisations hold a current record for Mianserin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1), Germany (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mianserin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mianserin

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mianserin. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ItalyCEP Company GMP cert on record
  • GermanyCEP Company GMP cert on record
  • LABORATORIOS ESPINOS Y BOFILL S.A.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SpainCEP
Need Mianserin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Mianserin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
LABORATORIOS ESPINOS Y BOFILL S.A. Cornella de LlobregatES
CEP 2021-183 - Rev 02
Mianserin hydrochloride, Process II
Aug 2026Inspected Apr 2023
Spain, outside 3-year window
ARCHIMICA S.P.A LodiIT
CEP 2022-250 - Rev 00
Mianserin hydrochloride
Nov 2024Inspected Feb 2026
Italy
EXCELLA GMBH & CO. KG FeuchtDE
CEP 2002-055 - Rev 07
Mianserin hydrochloride
Jun 2024Inspected Apr 2026
Germany

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Mianserin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • DIOSYNTH BV
    Inactive DMF 5945 · filed Aug 1985

Overview

Mianserin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL6437).

Chemical identity

IUPAC name
5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene
Canonical SMILES
CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42
InChIKey
UEQUQVLFIPOEMF-UHFFFAOYSA-N
Synonyms
J16.389I, Mianserin, Mianserina, Mianserine, Tolvon, Mianserinum, CHEBI:51137, RefChem:158482, N06AX03, Mianseryna [Polish], Mianseryna, Mianserine [INN-French]

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mianserin?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Mianserin: ARCHIMICA SPA (Italy), EXCELLA GMBH AND CO KG (Germany) and LABORATORIOS ESPINOS Y BOFILL S.A. (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Mianserin records mean?

1 organisation has only inactive Type II DMFs for Mianserin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mianserin have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Mianserin on the EDQM register, including LABORATORIOS ESPINOS Y BOFILL S.A. Cornella de Llobregat (ES), ARCHIMICA S.P.A Lodi (IT) and EXCELLA GMBH & CO. KG Feucht (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Mianserin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mianserin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.